Cervical Cancer in Nigeria: Symptoms, Causes, Prevention, and Treatment

Cervical cancer is one of the leading causes of cancer-related deaths among Nigerian women. However, it is highly preventable with regular screening and awareness. Most cases in Nigeria are linked to HPV infection, poor screening uptake, and late diagnosis. Understanding the risk factors, symptoms, and preventive measures is critical for Nigerian women.

Causes of Cervical Cancer in Nigeria

Persistent infection with high-risk HPV strains (especially HPV-16 and HPV-18) is the primary cause. Other factors prevalent in Nigeria include:

Limited access to regular cervical cancer screening

Multiple pregnancies or early sexual activity

Tobacco smoking (less common but significant in some regions)

Weakened immunity (HIV infection is a risk factor in Nigeria)

Symptoms of Cervical Cancer

Many Nigerian women are diagnosed late because early-stage cervical cancer often has no symptoms. Common warning signs include:

Abnormal vaginal bleeding (between periods or after sex)

Unusual vaginal discharge

Pelvic or lower abdominal pain

Pain during sexual intercourse

Prevention of Cervical Cancer in Nigeria

Preventive measures can save lives:

1. HPV Vaccination: Available in some Nigerian hospitals and private clinics; recommended for girls aged 9–14.
2. Regular Pap Smear Tests: Can be done at teaching hospitals and selected clinics across Nigeria.
3. HPV DNA Testing: Identifies high-risk HPV strains before cancer develops.
4. Safe Sexual Practices: Reducing number of sexual partners and consistent condom use.
5. Healthy Lifestyle: Avoid smoking, eat nutritious food, and maintain immunity.

Diagnosis and Screening

Early diagnosis is critical:

Pap Smear Test: Widely available in major Nigerian cities like Lagos, Abuja, and Port Harcourt.

HPV DNA Test: Detects high-risk HPV infections early.

Colposcopy: For women with abnormal Pap smear results.

Biopsy: Confirms cancer presence.

Treatment Options in Nigeria

Treatment depends on the stage of the disease:

Surgery: Removal of cancerous tissue or hysterectomy at major hospitals.

Radiation Therapy: Available in federal teaching hospitals in Lagos, Abuja, and other states.

Chemotherapy: Used for advanced stages.

Targeted Therapy: Limited availability in private hospitals.

Cervical Cancer Survival in Nigeria

Early detection improves survival, but late presentation is common:

Early-stage cervical cancer: high survival if treated promptly

Advanced-stage cervical cancer: Lower survival, highlighting the need for awareness and early screening

Frequently Asked Questions (FAQ)

1. What age group is most at risk in Nigeria?
   Women aged 30–50 years are at higher risk, though HPV vaccination can reduce risk in younger women.
2. Can cervical cancer be prevented in Nigeria?
   Yes, through HPV vaccination, regular screening (Pap smear/HPV test), and safe sexual practices.
3. How often should I get screened in Nigeria?

Ages 21–29: Pap smear every 3 years

Ages 30–65: Pap smear + HPV DNA test every 5 years

4. Where can I get screened or treated in Nigeria?
   Major teaching hospitals in Lagos, Abuja, Port Harcourt, and private specialist hospitals offer cervical cancer screening and treatment services.
5. Is cervical cancer hereditary?
   Cervical cancer is not directly inherited, but genetic factors may influence susceptibility to HPV-related cancers.
6. What are the side effects of treatment in Nigeria?
   Common side effects include fatigue, nausea, sexual dysfunction, and early menopause depending on therapy.

Conclusion

Cervical cancer is largely preventable with awareness, regular screenings, and vaccination. Nigerian women should take advantage of available healthcare facilities for early detection and treatment.

Call-to-Action:
Protect your health—book a Pap smear or HPV vaccination at your nearest Nigerian hospital today. Early detection saves lives.